The Bishop and Connell labs developed a small molecule RAD51 inhibitor, RI-1, that blocks RAD51 binding to ssDNA[200] and radiosensitizes glioma and glioblastoma cells[161,162]. Here, RAD51 is linked to central nervous system cancer.